-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

626.O1.6 626. Aggressive Lymphomas: Clinical and Epidemiological: CARs, Bispecifics, and ADCs: Progress and Challenges in Aggressive B Cell Lymphoma

Symposia: Aggressive Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Non-Hodgkin lymphoma, Lymphomas, Translational Research, Epidemiology, Clinical Practice (Health Services and Quality), Clinical Research, B Cell lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Health outcomes research, Diseases, Real-world evidence, Aggressive lymphoma, Treatment Considerations, Biological therapies, Registries, Lymphoid Malignancies, Biological Processes, Technology and Procedures, Study Population, Human, Measurable Residual Disease , Pathology
Sunday, December 8, 2024: 9:30 AM-11:00 AM
Marriott Grand Ballroom 8-9 (Marriott Marquis San Diego Marina)
Moderators:
Thomas Stauffer Larsen, MD, PhD, ARRAY(0xe93e210) and Dai Chihara, MD, PhD, National Institute of Health
Disclosures:
Chihara: BMS: Research Funding; Genentech: Research Funding; Ono pharmaceutical: Research Funding; Genmab: Research Funding; BeiGene: Honoraria; SymBio pharmaceutical: Honoraria.
In this session longer term follow-up and additional analyses on recent strategies for treatment of  aggressive b-cell lymphoma will be presented.
9:30 AM

Gilles Salles, MD, PhD1, Franck Morschhauser, MD, PhD2, Laurie H. H. Sehn, MD3, Alex F. Herrera, MD4, Jonathan W. Friedberg, MD5, Marek Trněný, MD, CSc6, Georg Lenz7, Jeff P. Sharman, MD8, Charles Herbaux, MD, PhD9*, John M. Burke10, Matthew Matasar, MD, MS11, Graham P. Collins12, Yuqin Song, MD13, Antonio Pinto14*, Shinya Rai, MD, PhD15*, Koji Izutsu, MD, PhD16, Calvin Lee, MD17*, Saibah Chohan, MSc17*, Matthew Sugidono, PharmD17*, Yanwen Jiang17*, Connie Lee Batlevi, MD, PhD17*, Mark Yan, PhD18*, Jamie Hirata, PharmD17*, Hervé Tilly19 and Christopher R. Flowers, MD, MS20

1Memorial Sloan Kettering Cancer Center, New York, NY
2University of Lille, Lille, France
3BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
4City of Hope, Duarte, CA
5Wilmot Cancer Institute, University of Rochester, Rochester, NY
6Charles University, Prague, Czech Republic
7University Hospital Münster, Münster, Germany
8Willamette Valley Cancer Institute and Research Center, Florence, OR
9University of Montpellier, Montpellier, France
10Rocky Mountain Cancer Centers, US Oncology Research, Aurora, CO
11Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
12Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
13Peking University Cancer Hospital, Beijing, China
14National Cancer Institute, Fondazione G. Pascale, IRCCS, Naples, Italy
15Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-Sayama City, Japan
16National Cancer Center Hospital, Tokyo, Japan
17Genentech, Inc., South San Francisco, CA
18Hoffmann-La Roche Ltd, Mississauga, ON, Canada
19Centre Henri-Becquerel and University of Rouen, Rouen, France
20M.D. Anderson Cancer Center, Houston, TX

9:45 AM

Maria Silvina Odstrcil Bobillo, MD1*, Swetha Kambhampati, MD2, Dasom Lee3, Bradley D. Hunter, MD, MPH4, Ogechukwu Egini, MD, MS5*, Krish Patel, MD6, Patrick M. Reagan, MD7, David Bernasconi, MSc8*, Soyoung Kim, PhD9*, Charimar Santiago Parrilla, MPH10*, Tracy Krimmel, MSN, DNP11*, Fei Fei Liu, GDCE, MBA11*, Debasmita Roy, PhD11*, Sairah Ahmed, MD12, Jennifer L. Crombie, MD13, Saurabh Dahiya, MD, FACP14,15*, Mehdi Hamadani, MD16, Catherine J. Lee, MD, MSc17, Marcelo C. Pasquini, MD, MS9, Mazyar Shadman, MD, MPH18*, Alex F. Herrera, MD19 and Matthew Frigault, MD, MS20

1University of Utah School of Medicine, Salt Lake City, UT
2City of Hope National Medical Center, Duarte, CA
3Stanford School of Medicine, Stanford, CA
4Intermountain LDS Hospital, Salt Lake City, UT
5Rutgers Cancer Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
6Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle, WA
7University of Rochester Medical Center, Rochester, NY
8Bristol Myers Squibb, Boudry, Switzerland
9Center for International Blood & Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI
10Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
11Bristol Myers Squibb, Princeton, NJ
12MD Anderson Cancer Center, Houston, TX
13Dana-Farber Cancer Institute, Boston, MA
14Stanford University School of Medicine, Stanford, CA
15University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
16BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI
17Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
18Fred Hutch Cancer Center, University of Washington, Seattle, WA
19Duarte Cancer Center, City of Hope Medical Center, Duarte, CA
20Massachusetts General Hospital, Boston, MA

10:00 AM

Gloria Iacoboni, MD1*, Kai Rejeski, MD2, Victor Navarro Garces, BSc3*, Tom van Meerten4*, Alex Rampotas5*, Ana Africa Martin Lopez, MD6*, Juan Luis Reguera, MD7*, Mariana Bastos-Oreiro8*, Claire Roddie, MD5*, Ana Benzaquen, MD9*, Cecilia Carpio1*, Javier Delgado Serrano7*, Maria Landwehr, MD10*, Sophia Stock, MD11*, Pablo Silva De Tena12*, Pau Abrisqueta Costa1*, Janneke W. De Boer, MD4*, Lucia Lopez Corral, MD6*, Rafael Hernani9*, Marion Subklewe, MD13, Mi Kwon, MD, PhD12, Maeve O'Reilly14* and Pere Barba, MD1

1University Hospital Vall d’Hebron, Barcelona, Spain
2Hematology/Oncology, LMU University Hospital, Department of Medicine III, Munich, Germany
3Statistics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
4Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
5University College London Cancer Institute, London, United Kingdom
6Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
7University Hospital Virgen del Rocío, Sevilla, Spain
8Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
9Hospital Clínico Universitario-INCLIVA, Valencia, Spain
10Department of Hematology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
11Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
12Hospital General Universitario Gregorio Marañón, Madrid, Spain
13Department of Medicine III, LMU University Hospital, Munich, Germany
14Department of Hematology, University College London Hospitals, London, United Kingdom

10:15 AM

Sairah Ahmed, MD1, Avyakta Kallam, MD2*, Matthew Frigault, MD, MS3, Bradley D. Hunter, MD, MPH4, Sagar S. Patel, MD5, David Bernasconi, MSc6*, Soyoung Kim, PhD7*, Tracy Krimmel, MSN, DNP8*, Fei Fei Liu, GDCE, MBA8*, Debasmita Roy, PhD8*, Marcelo C. Pasquini, MD, MS7 and Jennifer L. Crombie, MD9

1MD Anderson Cancer Center, Houston, TX
2Duarte Cancer Center, City of Hope Medical Center, Duarte, CA
3Massachusetts General Hospital, Boston, MA
4Intermountain LDS Hospital, Salt Lake City, UT
5Transplant and Cellular Therapy Program, University of Utah Huntsman Cancer Institute, Salt Lake City, UT
6Bristol Myers Squibb, Boudry, Switzerland
7Center for International Blood & Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI
8Bristol Myers Squibb, Princeton, NJ
9Dana-Farber Cancer Institute, Boston, MA

10:30 AM

Megan Melody, MD1, Natalie Grover, MD2, Stephanie Franco, MD3, Jason T Romancik, MD4, Matthew J Cortese, MD, MPH5, Tamara K Moyo, MD6*, Rahul S Bhansali, MD7, Thomas Ollila, MD8, Vaishalee P Kenkre, MD9, Lindsey Fitzgerald, MD10, Brian Hess, MD11, Matthew Matasar, MD, MS12, Geoffrey Shouse, PhD, DO13, Kaitlin Annunzio, DO14, Megan M Herr, PhD15, James A Davis, PharmD16*, Christy Jesme, MD10*, Ari Pelcovits, MD17, Jonathan Moreira, MD18, Shuo Ma, MD, PhD18, Jane N Winter, MD19, Adam Yuh Lin, MD PhD18, Alexey Danilov, MD, PhD20, Ishan Roy, MD, PhD21, Stefan K. Barta, MD7, Leo I. Gordon, MD22, Deborah M. Stephens, DO23, Jonathon B Cohen, MD MS24, Narendranath Epperla, MD MS14 and Reem Karmali, MD25

1Feinberg School of Medicine, Northwestern University, Chicago, IL
2University of North Carolina, Chapel Hill, NC
3Feinberg School of Medicine,, Northwestern University, Chicago, IL
4Winship Cancer Institute, Emory University, Atlanta, GA
5Roswell Park Comprehensive Cancer Center, Department of Medicine (Lymphoma Section), Buffalo, NY
6Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
7Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
8Brown University, Providence, RI
9Carbone Cancer Center, University of Wisconsin–Madison, Madison, WI
10Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
11Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
12Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ
13City of Hope Cancer Center, Duarte, CA
14Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
15Roswell Park Comprehensive Cancer Center, Buffalo, NY
16Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
17Rhode Island Hospital, Providence, RI
18Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
19Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
20City of Hope Comprehensive Cancer Center, Duarte, CA
21Shirley Ryan Ability Lab, Chicago, IL
22Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
23University of North Carolina Chapel Hill, Chapel Hill, NC
24Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
25Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL

10:45 AM

Thomas Hueso, MD; PhD1*, Jessy Alchidiac, MD1*, Maria-Rosa Ghigna, MD1*, Arnaud Pages, MD; PhD1*, Cyril Quivoron, PhD2*, Camille Bigenwald, MD; PhD2*, Loic Renaud, MD; PhD1*, Cristina Castilla-Llorente, MD3*, Alexandre Eeckhoutte, PhD4*, Serge Bologna, MD5*, Veronique Morel, MD6*, Vincent Delwail, MD7*, Pierre Feugier, MD, PhD8*, Catherine Thieblemont, MD9, Olivier Bernard, PhD10*, Peggy Dartigues, MD11*, Christophe Massard, MD; PhD1*, Vincent Ribrag, MD12,13 and Jean-Marie Michot3*

1Gustave Roussy Institute, Villejuif, France
2Gustave Roussy, VILLEJUIF, France
3Gustave Roussy Cancer Campus, Villejuif, France
4INSERM, Villejuif, FRA
5Clinique Louis Pasteur, Essey Les Nancy, FRA
6Clinical Hematology, Pitie-Salpetriere Hospital, APHP, Sorbonne Universite, Paris Cedex 13, FRA
7Hematology, CHU Poitiers, Poitiers, FRA
8Department of Haematology, Centre Hospitalier Régional Universitaire (CHRU) de Nancy, Vandoeuvre-lès-Nancy, France
9Hospital Saint-Louis, Paris, France
10INSERM, Villejuif, France
11Department of Pathology, Gustave Roussy, Villejuif, France
12Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer,, Villejuif, France
13Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer, Villejuif, France

*signifies non-member of ASH